Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
Fraser, G, Cramer, P, Demirkan, F, Silva, R Santucci, Grosicki, S, Pristupa, A, Janssens, A, Mayer, J, Bartlett, N L, Dilhuydy, M-S, Pylypenko, H, Loscertales, J, Avigdor, A, Rule, S, Villa, D, Samoilova, O, Panagiotidis, P, Goy, A, Pavlovsky, M A, Karlsson, C, Hallek, M, Mahler, M, Salman, M, Sun, S, Phelps, C, Balasubramanian, S, Howes, A, Chanan-Khan, A
Published in Leukemia (01.04.2019)
Published in Leukemia (01.04.2019)
Get full text
Journal Article
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
Bartlett, NL, Niedzwiecki, D, Johnson, JL, Friedberg, JW, Johnson, KB, van Besien, K, Zelenetz, AD, Cheson, BD, Canellos, GP
Published in Annals of oncology (01.06.2007)
Published in Annals of oncology (01.06.2007)
Get full text
Journal Article
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
WITZIG, Thomas E, GORDON, Leo I, GRILLO-LOPEZ, Antonio J, MULTANI, Pratik, WHITE, Christine A, CABANILLAS, Fernando, CZUCZMAN, Myron S, EMMANOUILIDES, Christos, JOYCE, Robin, POHLMAN, Brad L, BARTLETT, Nancy L, WISEMAN, Gregory A, PADRE, Norman
Published in Journal of clinical oncology (15.05.2002)
Published in Journal of clinical oncology (15.05.2002)
Get full text
Journal Article
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial
Wiseman, Gregory A., Gordon, Leo I., Multani, Pratik S., Witzig, Thomas E., Spies, Stewart, Bartlett, Nancy L., Schilder, Russell J., Murray, James L., Saleh, Mansoor, Allen, Roberta S., Grillo-López, Antonio J., White, Christine A.
Published in Blood (15.06.2002)
Published in Blood (15.06.2002)
Get full text
Journal Article
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
Ekstrand, Bradley C., Lucas, Jennifer B., Horwitz, Steven M., Fan, Zhen, Breslin, Sheila, Hoppe, Richard T., Natkunam, Yasodha, Bartlett, Nancy L., Horning, Sandra J.
Published in Blood (01.06.2003)
Published in Blood (01.06.2003)
Get full text
Journal Article
HIGH PROLIFERATION (MCL35 ASSAY) IS ASSOCIATED WITH INFERIOR OUTCOMES IN PATIENTS TREATED WITH INTENSIVE REGIMENS—A CORRELATIVE STUDY FROM THE CALGB 50403 (ALLIANCE) TRIAL
Scott, D.W., Pitcher, B., Liu, Y., Boyle, M., Mottok, A., Said, J., Chadburn, A., Lai, R., Jung, S., Bartlett, N.L., Leonard, J.P., Kaplan, L.D., Hsi, E.D.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
FINAL RESULTS OF CALGB 50803 (ALLIANCE): A PHASE 2 TRIAL OF LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA
Martin, P., Jung, S., Pitcher, B., Bartlett, N.L., Blum, K.A., Shea, T., Ruan, J., Smith, S.E., Leonard, J.P., Cheson, B.D.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
INTERIM RESULTS FROM a PHASE 1/2 STUDY OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA
Herrera, A.F., Moskowitz, A.J., Bartlett, N.L., Vose, J.M., Ramchandren, R., Feldman, T.A., Lacasce, A.S., Ansell, S.M., Moskowitz, C.H., Fenton, K., Ogden, C., Taft, D., Zhang, Q., Kato, K., Campbell, M., Advani, R.H.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
BEYOND MAXIMUM GRADE: A NOVEL, LONGITUDINAL TOXICITY OVER TIME (TOXT) ADVERSE EVENT ANALYSIS OF LENALIDOMIDE IN FOLLICULAR LYMPHOMA IN CALGB 50401 (ALLIANCE)
Thanarajasingam, G., Dueck, A.C., Novotny, P.J., Witzig, T.E., Habermann, T.M., Nowakowski, G.S., Flowers, C.R., Bartlett, N.L., Blum, K.A., Pitcher, B.N., Jung, S., Atherton, P.J., Tan, A.D., Sloan, J.A., Leonard, J.P.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
AXICABTAGENE CILOLEUCEL (AXI‐CEL; KTE‐C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON‐HODGKIN LYMPHOMAS (NHL): PRIMARY RESULTS OF THE PIVOTAL TRIAL ZUMA‐1
Neelapu, S.S., Locke, F.L., Bartlett, N.L., Lekakis, L.J., Miklos, D., Jacobson, C.A., Braunschweig, I., Oluwole, O., Siddiqi, T., Lin, Y., Timmerman, J., Reagan, P., Navale, L., Jiang, Y., Aycock, J., Elias, M., Wiezorek, J., Go, W.Y.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
RISK‐ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA‐EPOCH‐R
Dunleavy, K., Roschewski, M., Abramson, J.S., Link, B., Parekh, S., Jagadeesh, D., Bierman, P., Watson, P.R., Peace, D., Hanna, W., Powell, B., Melani, C., Lucas, A., Steinberg, S.M., Kahl, B., Friedberg, J.W., Little, R.F., Bartlett, N.L., Fanale, M.A., Noy, A., Wilson, W.H.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma
Chen, Robert, Allibone, Suzanne, Bartlett, Nancy L, Brice, Pauline, Chen, Andy, Pose, Katrina, Rich, Lynn, Bonthapally, Vijay, Garfin, Phillip M, Fanale, Michelle
Published in OncoTargets and therapy (01.01.2016)
Published in OncoTargets and therapy (01.01.2016)
Get full text
Journal Article
THE 23‐GENE GENE EXPRESSION‐BASED ASSAY DOES NOT PREDICT INTERIM PET SCAN RESULTS AFTER ABVD IN ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN THE US INTERGROUP S0816 TRIAL
Scott, D.W., Li, H., Harvey, Y., Chan, F., Mottok, A., Boyle, M., Evens, A.M., Schoder, H., Straus, D.J., Bartlett, N.L., Sweetenham, J.W., Barr, P.M., Fanale, M.A., Hsi, E.D., Cook, J.R., Kahl, B.S., Leonard, J.P., Friedberg, J.W., Leblanc, M., Steidl, C., Gascoyne, R.D., Rimsza, L.M., Press, O.W.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma
Wiseman, Gregory A, White, Christine A, Sparks, Richard B, Erwin, William D, Podoloff, Donald A, Lamonica, Dominick, Bartlett, Nancy L, Anthony Parker, J, Dunn, William L, Spies, Stewart M, Belanger, Richard, Witzig, Thomas E, Leigh, Bryan R
Published in Critical reviews in oncology/hematology (01.07.2001)
Published in Critical reviews in oncology/hematology (01.07.2001)
Get full text
Journal Article
Assessment of the Stanford V Regimen and Consolidative Radiotherapy for Bulky and Advanced Hodgkin’s Disease: Eastern Cooperative Oncology Group Pilot Study E1492
HORNING, S. J, WILLIAMS, J, BARTLETT, N. L, BENNETT, J. M, HOPPE, R. T, NEUBERG, D, CASSILETH, P
Published in Journal of clinical oncology (01.03.2000)
Published in Journal of clinical oncology (01.03.2000)
Get full text
Journal Article
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance
Bartlett, N L, Lum, B L, Fisher, G A, Brophy, N A, Ehsan, M N, Halsey, J, Sikic, B I
Published in Journal of clinical oncology (01.04.1994)
Published in Journal of clinical oncology (01.04.1994)
Get more information
Journal Article